ATBECHDE....FRGB..ITLILUNLSE........................................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0416011A119910313EP89906537.01989051219901120enenen1988019417119880516US1989033408919890405US1991031319911119910313199111

A61K C I

A61K 45/ 06 A I

A61K 9/ 127 A I

A61K 9/ 66 A I

A61K 31/ 24 A I

A61K 31/ 40 A I

A61K 31/ 44 A I

A61K 31/ 445 A I

A61K 31/ 47 A I

A61K 31/ 475 A I

A61K 31/ 495 A I

A61K 31/ 505 A I

A61K 31/ 52 A I

A61K 31/ 55 A I

A61K 31/ 70 A I

A61K 45/ 00 A I

A61P 31/ 12 A I

A61P 31/ 18 A I

A61P 37/ 04 A I

B01J 13/ 02 A I

enCHEMOTHERAPEUTIC COMPOSITION FOR AIDSfrCOMPOSITION CHIMIOTHERAPEUTIQUE POUR LE TRAITEMENT DU SIDAdeCHEMOTHERAPEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON AIDSTHE UNITED STATES OF AMERICA, as represented by THE SECRETARY, U.S. DEPARTMENT OF COMMERCE5285 Port Royal RoadSpringfield, VA 22161USWEINSTEIN, John, N.4705 Falstone AvenueChevy Chase, MD 20815USSZEBENI, Janos6015 Sonoma RoadBethesda, MD 20817USJump, Timothy John Simon, et alVenner Shipley & Co. 20 Little BritainLondon EC1A 7DHGBATBECHDEFRGBITLILUNLSEUS198900203419890512enWO198901127419891130198928